1370355-71-7Relevant academic research and scientific papers
C-Met inhibitors as novel fused ring heterocyclic derivatives
-
, (2016/10/17)
This invention relates to a novel fused quinazoline derivative (represented by the formula I) useful as a c-Met inhibitor, its synthesis and application for treating c-Met mediated disorders. In particular, this invention relates to a fused heterocyclic derivative useful as a c-Met inhibitor, its synthesis and application for treating c-Met mediated disorders.
Novel Fused Heterocyclic Derivatives Useful as c-Met Tyrosine Kinase Inhibitors
-
, (2013/05/22)
Certain novel fused quinazoline derivatives of formula (I) as c-Met inhibitors, their synthesis and their uses for treating a c-Met mediated disorder. Methods for treating a c-Met-mediated disorder are also disclosed in the invention.
NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
-
, (2012/02/02)
Certain novel fused quinazoline derivatives of formula (I) as c-Met inhibitors, their synthesis and their uses for treating a c-Met mediated disorder. Methods for treating a c-Met-mediated disorder are also disclosed in the invention.
